New pill formulation tested for better absorption in healthy volunteers
NCT ID NCT07222878
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new version of NPT 2042 soft-gelatin capsules to see if it is absorbed better than the original version. Eight healthy adults took single doses of both formulations. The goal was to measure how the drug moves through the body, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Lincoln, Nebraska, 68502, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain surgery meets brain science: probing how a memory-related chemical system influences cognition
- Can tracking thousands of dementia cases reshape how we care for patients?
- Scientists probe the brain's decision-making circuitry one neuron at a time
- Spotting the warning signs of drug-resistant epilepsy in children
- PET scans probe link between brain inflammation and Alzheimer's damage
- Can sound waves soothe Dementia's emotional turmoil?